Trial intelligence / Profile preview

Doxycycline for MALT Lymphoma of the Ocular Adnexae (IELSG27)

NCT01010295Phase 2Completed

Sponsor
International Extranodal Lymphoma Study Group
Start
Sep 2006
Primary completion
Dec 2011
Modality
Small Molecules
Countries
4
01

Overview

A Phase 2 trial of doxycycline in extranodal marginal zone B cell lymphoma of mucosa-associated lymphoid tissue, sponsored by International Extranodal Lymphoma Study Group. Started Sep 2006; status: completed.

02

Drugs

doxycycline
03

Conditions

extranodal marginal zone B cell lymphoma of mucosa-associated lymphoid tissue

Beyond the preview

Go deeper on NCT01010295.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01010295.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call